Sort
82,697 grants matching “vaccine development”
Fogarty AIDS International Training and Research Program (AITRP)
$734,715Chris Beyrer · Johns Hopkins University · D43 · FY2012 · TW
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
$734,665Shabaana A. Khader · Washington University · R01 · FY2020 · AI
Chikungunya Virus Replication and Pathogenesis
$734,664Terence S. Dermody · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · AI
Enviromental Factors in the Etiology of Autism
$734,527University Of California Davis · P01 · FY2002 · ES
Enhancing immunity to malaria in young children with effective chemoprevention
$734,418Prasanna Jagannathan · Stanford University · U01 · FY2025 · AI
Norovirus 3CL Protease-Based Anti-norovirus Therapeutics
$734,295Kyeong-Ok Chang · Kansas State University · R01 · FY2018 · AI
Norovirus 3CL Protease-Based Anti-norovirus Therapeutics
$734,295Kyeong-Ok Chang · Kansas State University · R01 · FY2017 · AI
Norovirus 3CL Protease-Based Anti-norovirus Therapeutics
$734,295Kyeong-Ok Chang · Kansas State University · R01 · FY2015 · AI
Norovirus 3CL Protease-Based Anti-norovirus Therapeutics
$734,295Kyeong-Ok Chang · Kansas State University · R01 · FY2016 · AI
Extent and Significance of Bacterial DNA Integrations in the Human Cancer Genome
$734,269Julie Dunning Hotopp · University Of Maryland Baltimore · R01 · FY2016 · CA
Rochester Roybal Center for Social Ties and Aging Research
$734,220Kathi L Heffner · University Of Rochester · P30 · FY2021 · AG
Rochester Roybal Center for Social Ties and Aging Research
$734,220Kathi L Heffner · University Of Rochester · P30 · FY2020 · AG
Universal VLP-Based Flu Vaccine:Broadly protective (universal) virus-like particle (VLP) based influenza vaccine that can neutralize a broad spectrum of influenza A virus subtypes.
$734,219Jose M Galarza · Technovax, Inc. · R44 · FY2019 · AI
Development of a Universal Influenza Vaccine
$734,209Frank R. Jones · Etubics Corporation · R01 · FY2018 · AI
Core F -Integrated Support Services Core
$734,179Joan Elizabeth Nichols · University Of Texas Med Br Galveston · UC7 · FY2023 · AI
Visceral Leishmanasis in Bihar State, Indian
$734,158Shyam Sundar · Banaras Hindu University · P50 · FY2008 · AI
SVEU - CONDUCT OF STUDIES IN NONHUMAN PRIMATES: REIMMUNIZATION AND CHALLENG
$734,103Thomas Patterson · Advanced Bioscience Laboratories, Inc. · N01 · FY2013 · AI
Support of Yerkes National Primate Research Center
$734,000Michael M Johns · Emory University · P51 · FY2006 · RR
Consortium for HIV/AIDS Vaccine Development
$733,872Dennis R. Burton · Scripps Research Institute, The · UM1 · FY2019 · AI
Vaccine- and infection-derived correlates of protection for cholera
$733,746Jason B Harris · Massachusetts General Hospital · R01 · FY2024 · AI
Small Molecule Protease Inhibitors against MERS-CoV and Coronaviruses of Pandemic Potential
$733,730Kyeong-Ok Chang · Kansas State University · R01 · FY2025 · AI
Development of a novel adjuvant strategy enabled by modulation of the physical properties of fungal mannans
$733,725Ivan Zanoni · Boston Children'S Hospital · R01 · FY2025 · AI
Evolutionary multispecies transcriptomics to reveal genes that govern fungal spore germination and pathogenesis
$733,720Jeffrey Peter Townsend · Yale University · R01 · FY2023 · AI
Improvements to Biopharmaceutical Manufacturing
$733,711Susan T Sharfstein · Hocuslocus, Inc. · R42 · FY2017 · GM
Genetics of Coxiella burnetii
$733,686Robert A Heinzen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI